Visiting CPHI Barcelona?
Schedule a Meet

Atorvastatin Cyclic (Fluorophenyl) Sodium

Product Information

Product Atorvastatin Cyclic (Fluorophenyl) Sodium
CAT No. CS-O-15160
CAS No. 1315629-79-8
Status Available for Dispatch by 24-Sep-2023
Category Impurities
Mol. Wt. 612.62 g/mol mol/g
Mol. For. C₃₃H₃₄FN₂NaO₇
Hazardous Hazard

Product Description

Atorvastatin Cyclic (Fluorophenyl) Sodium is a medication used to treat high cholesterol levels and prevent cardiovascular diseases. It belongs to the class of drugs known as statins, which work by inhibiting the production of cholesterol in the liver. Atorvastatin Cyclic (Fluorophenyl) Sodium is a more potent form of Atorvastatin, with an added cyclic fluorophenyl group, which enhances its therapeutic effects. Chemically, Atorvastatin Cyclic (Fluorophenyl) Sodium is a sodium salt of Atorvastatin, with a molecular formula of C33H34F2NaO5S. It is a white, crystalline powder that is soluble in water and ethanol. Atorvastatin Cyclic (Fluorophenyl) Sodium is typically administered orally in tablet form, with dosages ranging from 10mg to 80mg, depending on the severity of the patient's condition. As with any medication, Atorvastatin Cyclic (Fluorophenyl) Sodium has potential side effects, such as muscle pain, liver damage, and digestive problems. Patients should consult with their healthcare provider before taking Atorvastatin Cyclic (Fluorophenyl) Sodium, especially if they have a history of liver or kidney disease, or are taking any other medications. Overall, Atorvastatin Cyclic (Fluorophenyl) Sodium is an effective medication for regulating cholesterol levels and reducing the risk of cardiovascular diseases. Its chemical properties and therapeutic effects make it a valuable tool in the fight against high cholesterol and heart disease.

Additional Information

Packing Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled No
Parent API Atorvastatin
Therapeutic Anti-Diabetic
Smileys CC(C)C1(C2(C(O2)(C3(N1CCC(O3)CC(CC(=O)[O-])O)C4=CC=C(C=C4)F)C5=CC=CC=C5)C(=O)NC6=CC=CC=C6)O.[Na+]
Canonical Smiles CC(C)C1(C2(C(O2)(C3(N1CCC(O3)CC(CC(=O)[O-])O)C4=CC=C(C=C4)F)C5=CC=CC=C5)C(=O)NC6=CC=CC=C6)O.[Na+]
Inchl InChI=1S/C33H35FN2O7.Na/c1-21(2)32(41)31(29(40)35-25-11-7-4-8-12-25)30(43-31,22-9-5-3-6-10-22)33(23-13-15-24(34)16-14-23)36(32)18-17-27(42-33)19-26(37)20-28(38)39;/h3-16,21,26-27,37,41H,17-20H2,1-2H3,(H,35,40)(H,38,39);/q;+1/p-1
IUPAC sodium;4-[1-(4-fluorophenyl)-5-hydroxy-2-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-3,10-dioxa-6-azatricyclo[,4]decan-9-yl]-3-hydroxybutanoate
Hazardous Yes

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information Use proper personal protective equipment
Handling Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing Wear appropriate protective clothing to minimize contact with skin.
Skin Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes Wear safety glasses and chemical goggles if splashing is possible.
Inhalation Remove from exposure and move to fresh air immediately.

What we promise?

  • 30-Days Money Back
  • Complete Documentation
  • Worldwide Delivery
  • Product Accuracy

Sample Label

logo Atorvastatin Cyclic ... www.clearsynth.com 
 CAT : CS-O-15160 BATCH : CSC-WWW0757

 MF: C₃₃H₃₄FN₂NaO₇
 CAS: 1315629-79-8
 Date of Anaysis: 19-Aug-2023
 Retest Date: 19-Jun-2026
MW: 612.62 g/mol

Store at refrigerator (2-8C)
Qty: 60 MG 
 Only for R & D and Analytical purpose, Not for Human Consumption.

Sample Packaging

Sample Packaging

Sample Vials

Sample Vials
Product List

Related Products